| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1537-2995.2010.02644.X |
| P698 | PubMed publication ID | 20412529 |
| P50 | author | Britta Eiz-Vesper | Q47158598 |
| P2093 | author name string | Peter A Horn | |
| Rainer Blasczyk | |||
| Axel Seltsam | |||
| Britta Eiz-Vesper | |||
| Constança Figueiredo | |||
| Lilia Goudeva | |||
| P433 | issue | 8 | |
| P304 | page(s) | 1690-1701 | |
| P577 | publication date | 2010-04-15 | |
| P1433 | published in | Transfusion | Q15758500 |
| P1476 | title | Generation of HLA-deficient platelets from hematopoietic progenitor cells | |
| P478 | volume | 50 |
| Q38416517 | A future with less HLA: potential clinical applications of HLA-universal cells |
| Q58124897 | A future without human leukocyte antigens? |
| Q35915095 | Alternative blood products and clinical needs in transfusion medicine |
| Q42186159 | Bone marrow stromal cells transduced with a thrombopoietin, interleukin-6, and interleukin-11 syncretic gene induce cord mononuclear cells to generate platelets in vitro. |
| Q38074224 | Challenges and promises for the development of donor-independent platelet transfusions |
| Q37871065 | Clinical relevance of the HLA system in blood transfusion |
| Q38187494 | Ex vivo production of platelets from stem cells |
| Q95323333 | Generation and characterization of HLA-universal platelets derived from induced pluripotent stem cells |
| Q33432719 | Generation of HLA-universal iPSCs-derived megakaryocytes and platelets for survival under refractoriness conditions |
| Q36160823 | HLA Class I Depleted hESC as a Source of Hypoimmunogenic Cells for Tissue Engineering Applications |
| Q34774684 | Immunological barriers to stem-cell based cardiac repair |
| Q97533489 | In vitro platelet production for transfusion purposes: Where are we now? |
| Q42223452 | MHC universal cells survive in an allogeneic environment after incompatible transplantation. |
| Q57180047 | NK cell development in a human stem cell niche: KIR expression occurs independently of the presence of HLA class I ligands |
| Q53734886 | Optimizing megakaryocyte polyploidization by targeting multiple pathways of cytokinesis. |
| Q92585772 | Platelet-derived bio-products: Classification update, applications, concerns and new perspectives |
| Q39076420 | Progress in bio-manufacture of platelets for transfusion |
| Q37597083 | Semaphorin 7A as a potential immune regulator and promising therapeutic target in rheumatoid arthritis |
| Q33400401 | Semaphorin 7A inhibits platelet production from CD34+ progenitor cells |
| Q92626445 | Silencing of HLA class I on primary human hepatocytes as a novel strategy for reduction in alloreactivity |
Search more.